- Home
- GOVX vs OXBR Comparison
GOVX vs OXBR Comparison
Compare GOVX & OXBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- OXBR
- Stock Information
- Founded
- GOVX 2001
- OXBR 2013
- Country
- GOVX United States
- OXBR Cayman Islands
- Employees
- GOVX N/A
- OXBR N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- OXBR Property-Casualty Insurers
- Sector
- GOVX Health Care
- OXBR Finance
- Exchange
- GOVX Nasdaq
- OXBR Nasdaq
- Market Cap
- GOVX 17.1M
- OXBR 15.8M
- IPO Year
- GOVX N/A
- OXBR 2014
- Fundamental
- Price
- GOVX $2.46
- OXBR $2.82
- Analyst Decision
- GOVX Strong Buy
- OXBR
- Analyst Count
- GOVX 5
- OXBR 0
- Target Price
- GOVX $14.20
- OXBR N/A
- AVG Volume (30 Days)
- GOVX 3.6M
- OXBR 14.1K
- Earning Date
- GOVX 11-12-2024
- OXBR 11-13-2024
- Dividend Yield
- GOVX N/A
- OXBR N/A
- EPS Growth
- GOVX N/A
- OXBR N/A
- EPS
- GOVX N/A
- OXBR N/A
- Revenue
- GOVX $3,090,161.00
- OXBR N/A
- Revenue This Year
- GOVX N/A
- OXBR N/A
- Revenue Next Year
- GOVX $565.58
- OXBR N/A
- P/E Ratio
- GOVX N/A
- OXBR N/A
- Revenue Growth
- GOVX N/A
- OXBR N/A
- 52 Week Low
- GOVX $1.09
- OXBR $0.87
- 52 Week High
- GOVX $11.18
- OXBR $3.72
- Technical
- Relative Strength Index (RSI)
- GOVX 52.48
- OXBR 55.44
- Support Level
- GOVX $2.31
- OXBR $2.41
- Resistance Level
- GOVX $3.88
- OXBR $2.97
- Average True Range (ATR)
- GOVX 0.32
- OXBR 0.21
- MACD
- GOVX 0.11
- OXBR -0.01
- Stochastic Oscillator
- GOVX 33.33
- OXBR 69.49
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
About OXBR Oxbridge Re Holdings Limited
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.